exubera (Pfizer Inc)
86
Structured Review
Pfizer Inc
exubera
Exubera, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/exubera/exubera/pm41833752-111-0-1
Average 86 stars, based on 1 article reviews
Exubera, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/exubera/exubera/pm41833752-111-0-1
Average 86 stars, based on 1 article reviews
exubera - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Formulation:Article Title: Form 10-K Article Snippet: The increase in Article Title: Form 10-K Article Snippet: Partnership with Article Title: Form 10-K Article Snippet: Table of Contents The decrease in contract research revenue in 2006 compared to 2005 was primarily due to a $34.8 million decrease in Article Title: Form 10-K Article Snippet: Our default under any of these agreements triggers Article Title: Peptide pharmaceuticals for insulin resistance Article Snippet: Lyophilized powders, especially glassy particles, containing the active peptide and an excipient are useful for delivery to the lung with good bioavailability, for example, see Article Title: Form 10-K Article Snippet: Partnership with Pfizer for Clinical Proteomics:Article Title: Form 10-K Article Snippet: The increase in Article Title: Form 10-K Article Snippet: Partnership with Article Title: Form 10-K Article Snippet: Table of Contents The decrease in contract research revenue in 2006 compared to 2005 was primarily due to a $34.8 million decrease in Article Title: Form 10-K Article Snippet: Our default under any of these agreements triggers Article Title: Peptide pharmaceuticals for insulin resistance Article Snippet: Lyophilized powders, especially glassy particles, containing the active peptide and an excipient are useful for delivery to the lung with good bioavailability, for example, see Article Title: Form 10-K Article Snippet: Partnership with Pfizer for Labeling:Article Title: Form 10-K Article Snippet: The increase in Article Title: Form 10-K Article Snippet: Partnership with Article Title: Form 10-K Article Snippet: Table of Contents The decrease in contract research revenue in 2006 compared to 2005 was primarily due to a $34.8 million decrease in Article Title: Form 10-K Article Snippet: Our default under any of these agreements triggers Article Title: Peptide pharmaceuticals for insulin resistance Article Snippet: Lyophilized powders, especially glassy particles, containing the active peptide and an excipient are useful for delivery to the lung with good bioavailability, for example, see Article Title: Form 10-K Article Snippet: Partnership with Pfizer for Activity Assay:Article Title: Form 10-K Article Snippet: The increase in Article Title: Form 10-K Article Snippet: Partnership with Article Title: Form 10-K Article Snippet: Table of Contents The decrease in contract research revenue in 2006 compared to 2005 was primarily due to a $34.8 million decrease in Article Title: Form 10-K Article Snippet: Our default under any of these agreements triggers Article Title: Peptide pharmaceuticals for insulin resistance Article Snippet: Lyophilized powders, especially glassy particles, containing the active peptide and an excipient are useful for delivery to the lung with good bioavailability, for example, see Article Title: Form 10-K Article Snippet: Partnership with Pfizer for |